tiprankstipranks
Trending News
More News >
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
Advertisement

Aardvark Therapeutics, Inc. (AARD) Technical Analysis

Compare
86 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Aardvark Therapeutics, Inc.’s (AARD) Moving Averages Convergence Divergence (MACD) indicator is -0.65, suggesting Aardvark Therapeutics, Inc. is a Buy.
Aardvark Therapeutics, Inc.’s (AARD) 20-Day exponential moving average is 10.49, while Aardvark Therapeutics, Inc.’s (AARD) share price is $9.5, making it a Sell.
Aardvark Therapeutics, Inc.’s (AARD) 50-Day exponential moving average is 11.22, while Aardvark Therapeutics, Inc.’s (AARD) share price is $9.5, making it a Sell.

Aardvark Therapeutics, Inc. (AARD) Pivot Points

Nov 26, 2025, 10:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.15
8.48
8.93
9.26
9.71
10.04
10.49
Fibonacci
8.48
8.78
8.97
9.26
9.56
9.75
10.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aardvark Therapeutics, Inc. (AARD) Moving Averages

Nov 26, 2025, 10:37 AM
Period
Simple
Exponential
MA5
9.72Sell
9.70Sell
MA10
10.15Sell
9.98Sell
MA20
10.36Sell
10.49Sell
MA50
12.14Sell
11.22Sell
MA100
11.57Sell
11.31Sell
MA200
Aardvark Therapeutics, Inc.’s (AARD) 10-Day exponential moving average is 9.98, while Aardvark Therapeutics, Inc.’s (AARD) share price is $9.5, making it a Sell.
Aardvark Therapeutics, Inc.’s (AARD) 100-Day exponential moving average is 11.31, while Aardvark Therapeutics, Inc.’s (AARD) share price is $9.5, making it a Sell.
Aardvark Therapeutics, Inc.’s (AARD) stock price is $9.5 and Aardvark Therapeutics, Inc.’s (AARD) 50-day simple moving average is 12.14, creating a Sell signal.
Aardvark Therapeutics, Inc.’s (AARD) stock price is $9.5 and Aardvark Therapeutics, Inc.’s (AARD) 100-day simple moving average is 11.57, creating a Sell signal.

Aardvark Therapeutics, Inc. (AARD) Technical Indicators

Nov 26, 2025, 10:37 AM
Name
Value
Implied Action
RSI (14)
40.12
Neutral
STOCH (9,6)
15.56
Buy
STOCHRSI (14)
16.62
Buy
MACD (12,26)
-0.65
Buy
ADX (14)
15.88
Buy
Williams %R
-74.72
Buy
CCI (14)
-130.05
Buy
ATR (14)
0.95
-
Ultimate Oscillator
40.44
Neutral
ROC
-3.06
Sell
Aardvark Therapeutics, Inc.’s (AARD) Relative Strength Index (RSI) is 40.12, creating a Neutral signal.
Aardvark Therapeutics, Inc.’s (AARD) Trend Strength Indicator (ADX) is 15.88, creating a Buy signal.
Aardvark Therapeutics, Inc.’s (AARD) Commodity Channel Index (CCI) is -130.05, creating a Buy signal.
Aardvark Therapeutics, Inc.’s (AARD) Price Rate of Change (ROC) is -3.06, creating a Sell signal.

FAQ

Is AARD a Buy, Hold, or Sell?
Based on AARD’s technical indicators, AARD is a Sell.
    What is AARD’s RSI (14)?
    AARD’s RSI (14) is 40.12, which suggests AARD is a Neutral.
      What is AARD’s MACD?
      AARD’s MACD is -0.65, which suggests AARD is a Buy.
        What is AARD’s 5-day moving average?
        AARD’s 5-day moving average is 9.72, which suggests AARD is a Sell.
          What is AARD’s 20-day moving average?
          AARD 20-day moving average is 10.36, which suggests AARD is a Sell.
            What is AARD’s 50-day moving average?
            AARD’s 50-day moving average is 12.14, which suggests AARD is a Sell.
              What is AARD’s 200-day moving average?
              Currently, no data Available
              What is AARD’s Williams % R (14)?
              AARD’s Williams % R (14) is -74.72, which suggests AARD is a Buy.
                What is AARD’s CCI (14)?
                AARD’s CCI (14) is -130.05, which suggests AARD is a Buy.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis